OCUPHIRE PHARMA INC (OCUP) Earnings History & Surprises
NASDAQ:OCUP • US67577R1023
1.17 USD
-0.16 (-12.03%)
At close: Oct 23, 2024
1.1601 USD
-0.01 (-0.85%)
After Hours: 10/23/2024, 8:00:03 PM
Past quarterly earnings results for OCUPHIRE PHARMA INC (OCUP), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Release DateNov 8, 2024
PeriodQ3 / 2024
EPS Estimate-$0.26
Revenue Estimate2.152M
Last Reported
Release DateAug 13, 2024
PeriodQ2 / 2024
EPS Reported-$0.30
EPS Surprise -15.34%
Revenue Surprise -55.68%
Beat Rate
19%
EPS and Revenuebeats vs estimates
Quarterly Earnings Results
EPS & Revenue History (USD)
Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q2 2024 | -0.30 | -0.26 | -15.34% | -25.00% | 1.112M | 2.509M | -55.68% | -69.73% |
| Q1 2024 | -0.29 | -0.14 | -112.17% | -3.57% | 1.711M | 4.337M | -60.55% | -2.17% |
| Q4 2023 | -0.21 | -0.05 | -292.16% | -113.29% | 1.691M | 5.456M | -69.01% | -95.76% |
| Q3 2023 | 0.25 | -0.23 | 210.40% | 213.64% | 11.935M | 3.086M | 286.75% | - |
| Q2 2023 | -0.24 | -0.23 | -4.11% | 4.00% | 3.674M | 2.474M | 48.50% | - |
| Q1 2023 | -0.28 | -0.16 | -78.25% | 20.00% | 1.749M | 3.01M | -41.89% | - |
| Q4 2022 | 1.58 | 0.99 | 60.11% | 551.43% | 39.85M | 30.034M | 32.68% | - |
| Q3 2022 | -0.22 | -0.29 | 25.19% | 12.00% | - | -100.00% | ||
| Q2 2022 | -0.25 | -0.34 | 26.18% | 51.92% | - | -100.00% | ||
| Q1 2022 | -0.35 | -0.36 | 1.96% | 25.53% | - | - | ||
| Q4 2021 | -0.35 | -0.29 | -19.70% | 93.24% | - | 100.00% | ||
| Q3 2021 | -0.25 | -0.37 | 31.54% | 24.24% | 490K | - | - | |
| Q2 2021 | -0.52 | -0.37 | -40.31% | 16.13% | 100K | - | - | |
| Q1 2021 | -0.47 | -0.73 | 35.33% | -213.33% | - | -100.00% | ||
| Q4 2020 | -5.18 | -0.43 | -1,109.15% | - | -1.15M | - | - | |
| Q3 2020 | -0.33 | - | - | - | - | |||
| Q2 2020 | -0.62 | - | - | - | - | |||
| Q1 2020 | -0.15 | - | - | 1.15M | - | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
1
Average EPS beat (4)
-52.32%
Max EPS beat (4)
210.41%
Min EPS beat (4)
-292.16%
Revenue beat statistics
Revenue beat (4)
1
Average Revenue beat (4)
25.38%
Max Revenue beat (4)
286.75%
Min Revenue beat (4)
-69.01%
Analysis
In the last 4 quarters, OCUP has beaten EPS estimates in 1 out of 4 releases
OCUP has beaten revenue estimates in 1 out of the last 4 releases
In the last 4 quarters, OCUP reported -52.3% below the EPS estimates on average.
In the last 4 quarters, OCUP has beaten the revenue estimates by 25.4% on average.
OCUPHIRE PHARMA INC / OCUP Earnings FAQ
When did OCUPHIRE PHARMA INC (OCUP) report earnings last quarter?
OCUPHIRE PHARMA INC (OCUP) last reported earnings on 8/13/2024.
Can you provide information on whether OCUPHIRE PHARMA INC beat earnings estimates in the last quarter?
OCUPHIRE PHARMA INC (OCUP) missed EPS estimates and missed revenue estimates in the most recent quarter.
Can you provide information on how often OCUPHIRE PHARMA INC beats earnings estimates?
In the last 4 quarters, OCUPHIRE PHARMA INC (OCUP) has beaten EPS estimates in 1 out of 4 releases.